News

Please find below, the latest news and announcements from the Anti-NMDA Receptor Encephalitis Foundation.

ExTINGUISH Trial Official Patient Advocacy Organisations (PAOs)

FYI, there are only two PAO’s that are official partners of the ExTINGUISH Trial. They are the Anti-NMDA Receptor Encephalitis Foundation and the Autoimmune Encephalitis Society. Their logos are affixed to the bottom of this communication. You can rest assured…

The Voices of Anti-NMDA – Jayden Liuzza

It’s time that we are seen and heard! The Foundation is honoured to hear the voice of our Ambassador, Jayden Liuzza. We believe that this is a more effective and powerful way for those of us affected by anti-NMDA to…

Meet Ambassador Jayden Liuzza

The Foundation is very proud to introduce our first and the world’s youngest Ambassador for Anti-NMDA receptor encephalitis, Jayden Liuzza. You may remember seeing Jayden in the world’s first ever medical report on anti-NMDA that was broadcast on Canada’s CTV…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience | Canadian Journal of Neurological Sciences From www.cambridge.org - November 16, 3:43 PM Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience - Volume 48 Issue 6   The…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis | Neurology Neuroimmunology & Neuroinflammation From nn.neurology.org - Today, 10:33 AM Immunotherapeutic strategies for GAD65-AE remain highly controversial.27 Most patients are considered to require immunotherapy, and early immunotherapy has been…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Long‐term cognitive outcome in anti‐NMDA receptor encephalitis - Heine - - Annals of Neurology From onlinelibrary.wiley.com - October 6, 8:42 AM Objective Cognitive dysfunction is a core symptom of NMDAR encephalitis, but detailed studies on prevalence, characteristics of cognitive deficits,…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Long‐term cognitive outcome in anti‐NMDA receptor encephalitis - Heine - - Annals of Neurology From onlinelibrary.wiley.com - October 6, 8:42 AM Objective Cognitive dysfunction is a core symptom of NMDAR encephalitis, but detailed studies on prevalence, characteristics of cognitive deficits,…